Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Christopher Davella"'
Autor:
Charles B. Wessel, Thomas R. Radomski, Christopher Davella, Natasha Parekh, William H. Shrank, Elizabeth C S Swart, Clark Veet, Inmaculada Hernandez
Publikováno v:
J Gen Intern Med
BACKGROUND: As healthcare reimbursement shifts from being volume to value-focused, new delivery models aim to coordinate care and improve quality. The patient-centered medical home (PCMH) model is one such model that aims to deliver coordinated, acce
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::08091cb1ec69b1581ace306029a10d06
https://doi.org/10.1007/s11606-019-05594-3
https://doi.org/10.1007/s11606-019-05594-3
Autor:
Rebecca Maniago, Jennifer Miao, Stephanie Jou, Gregory Sampang Calip, Shawn Huda, Lawrence N. Shulman, Erin Mary Bange, Aditi Puri Singh, Christopher Davella
Publikováno v:
Journal of Clinical Oncology. 40:381-381
381 Background: With the growing complexity and cost of cancer care, adoption of oncology pathway tools as clinical decision support (CDS) has increased at the point of care. These tools have been shown to improve care quality, reduce variations in c
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::9844ac4bd3aaf32c7bcc3452391f7f53
https://doi.org/10.1200/jco.2022.40.28_suppl.381
https://doi.org/10.1200/jco.2022.40.28_suppl.381
Autor:
Nikhil Yegya-Raman, Cole Friedes, Lova Sun, Melina Elpi Marmarelis, William C. Levin, Keith A. Cengel, Brian Lally, Christopher Davella, John A. Kosteva, Aditi Puri Singh, Roger B. Cohen, Charu Aggarwal, Christine Ciunci, Abigail T. Berman, Corey J. Langer, Steven J. Feigenberg
Publikováno v:
Journal of Clinical Oncology. 40:8523-8523
8523 Background: The PACIFIC trial demonstrated a 10% improvement in 5-year survival with the addition of consolidation durvalumab versus placebo after chemoradiation (CRT) in good performance status patients (pts) with stage III non-small cell lung
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::9f9b7a66ce29a851a3133ae0eb0840d2
https://doi.org/10.1200/jco.2022.40.16_suppl.8523
https://doi.org/10.1200/jco.2022.40.16_suppl.8523
Autor:
James Helstrom, Peter Whooley, Kenneth Patrick, Christopher Davella, Jessica Bauman, Brian L. Egleston, Martin J. Edelman, Emily Milano
Publikováno v:
Journal of Clinical Oncology. 38:7-7
7 Background: Studies suggest that many Emergency Department (ED) visits and hospitalizations for cancer patients may be preventable. CMS has made changes to the hospital outpatient reporting program (OP-35) targeting ED visits and admissions in trea
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::6c199f7fc3f6acee1fb5adec5b9d916e
https://doi.org/10.1200/jco.2020.38.29_suppl.7
https://doi.org/10.1200/jco.2020.38.29_suppl.7
Publikováno v:
Urologic oncology. 38(10)
Renal cell carcinoma (RCC) is a commonly diagnosed and histologically diverse urologic malignancy. Clear cell RCC (ccRCC) is by far the most common, followed by the papillary and chromophobe subtypes. Sarcomatoid differentiation is a morphologic chan
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::fa0847df127e5298592b33482cc26632
https://pubmed.ncbi.nlm.nih.gov/30478013
https://pubmed.ncbi.nlm.nih.gov/30478013
Autor:
G J. Van Londen, Rahul Atul Parikh, Leonard Joseph Appleman, Christopher Davella, Jimmy Mullally
Publikováno v:
Journal of Clinical Oncology. 36:207-207
207 Background: Prostate cancer accounts for approximately 10% of cancer deaths in men worldwide. Clinical trials for metastatic castrate resistant prostate cancer (mCRPC) have established survival benefit with use of abiraterone (ABI) with prednison
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::5a4de96e6b898b93e10acf24cf79cfae
https://doi.org/10.1200/jco.2018.36.34_suppl.207
https://doi.org/10.1200/jco.2018.36.34_suppl.207